New Perspectives in Treatment with Monoamine Oxidase Inhibitors
- 1 January 1990
- journal article
- Published by Taylor & Francis in International Review of Psychiatry
- Vol. 2 (3-4) , 331-340
- https://doi.org/10.3109/09540269009026604
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A Controlled Study of the Antidepressant Efficacy and Side Effects of ( — )-DeprenylArchives of General Psychiatry, 1989
- Pharmacotherapy of Borderline Personality DisorderArchives of General Psychiatry, 1988
- L-Deprenyl in Alzheimer's DiseaseArchives of General Psychiatry, 1987
- Imipramine and Chlordiazepoxide in Depressive and Anxiety DisordersArchives of General Psychiatry, 1986
- Treatment of Endogenous Anxiety With Phobic, Hysterical, and Hypochondriacal SymptomsArchives of General Psychiatry, 1980
- A Multiple-Dose, Controlled Study of Phenelzine in Depression-Anxiety StatesArchives of General Psychiatry, 1976
- The Monoamine Oxidase Inhibitor, Phenelzine, in the Treatment of Depressive-Anxiety StatesArchives of General Psychiatry, 1973
- The management of severe agoraphobia: A comparison of iproniazid and systematic desensitizationPsychopharmacology, 1973
- Tricyclic Antidepressants and Monoamine Oxidase InhibitorsArchives of General Psychiatry, 1971
- Interactions between sympathomimetic amines and a new monoamine oxidase inhibitorPsychopharmacology, 1970